| |
Air
GSK identifies, characterises and assesses emissions to the air
from operations so that we can minimise them or manage them in a
way that eliminates adverse impact to the public or the environment.
We have achieved significant reductions in solvent releases through
reformulation of final dosage forms using water-based technologies.
We have developed detailed guidance to support the EHS Standard
on Managing of Emissions to Air.
Read about our air emissions
Wastewater
GSK is committed to ensuring that discharges to the environment
are controlled to levels that will avoid adverse impact and conserve
resources. We have developed detailed guidance for the standard
that addresses wastewater management and have a target to reduce
chemical oxygen demand, a measure of water pollution.
Read about our wastewater
management
Waste
GSK identifies and assesses waste arising from site activities and
then minimises or manages waste through the following hierarchy:
- Eliminate or reduce waste generation whenever feasible.
- Substitute with sustainable materials whenever feasible to minimise
overall impacts on air, water and land.
- Reuse waste whenever feasible.
- Recycle wastes in a manner consistent with local regulatory
requirements.
- Use treatment and disposal options that minimise the overall
EHS risks and impacts on air, water and land.
Read about our waste management
Natural
Resources
GSK strives to reduce natural resource consumption by our operations
to minimise impact on the environment. GSK has adopted global standards
on Sustainable Development, Energy Efficiency, Water Management
and Biodiversity to ensure the sustainability of our operations.
The Corporate Environment, Health and Safety department works with
Procurement, Engineering Technology and Capital Management and other
corporate functions to identify and implement natural resource conservation
projects.
Read about our water usage
 |
|
|
GSK recognises that managing energy supply can result
in short term savings, but medium and long-term savings
come from energy conservation and efficiency measures.
So the company has a Global Utilities Sourcing group
that evaluates energy usage throughout our manufacturing
and R&D operations. This group focuses on both energy
supply and energy demand because decreasing the amount
of electricity and fuel used saves money and also is
closely tied to a decrease in CO2 production,
a significant environmental benefit.
To foster on-going energy savings, many sites have
"energy teams" or "energy champions"
that monitor energy use, make energy conservation suggestions
and set energy conservation targets. In addition to
site-based programmes, operational organisations, such
as the company's pharmaceutical division, also have
energy-user groups which set energy conservation targets.
Over the last two years, GSK has sought an external
perspective on our energy management. An external energy
consulting company has conducted energy audits at eight
GSK manufacturing and four GSK R&D sites. Many of
their suggestions have been implemented including installation
of energy efficient lighting, motion sensors to automatically
turn off lights, energy efficient boilers and computer
display screens, and automated thermostat set-back in
facililites that have automated building control systems.
Over time we expect these to contribute to decreases
in electricity and fuel use.
|
Read
about our R&D energy programmes |
|
|
